We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
- Authors
Rastogi, Priya; Buyse, Marc E; Swain, Sandra M; Jacobs, Samuel A; Robidoux, André; Liepman, Marcia K; Pajon, Eduardo R; Dy, Philip A; Posada, Juan G, Jr; Melnik, Marianne K; Piette, Fanny; Geyer, Charles E, Jr; Mamounas, Elfetherios P; Wolmark, Norman
- Abstract
Bevacizumab with chemotherapy improves outcomes in patients with metastatic breast cancer (MBC). The purpose of this trial was to determine the activity and safety profile of neoadjuvant bevacizumab with chemotherapy in women with locally advanced breast cancer (LABC).
- Publication
Clinical breast cancer, 2011, Vol 11, Issue 4, p228
- ISSN
1938-0666
- Publication type
Journal Article
- DOI
10.1016/j.clbc.2011.04.001